Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases

Biomed Pharmacother. 2021 Jul:139:111572. doi: 10.1016/j.biopha.2021.111572. Epub 2021 Apr 7.

Abstract

Long non-coding RNAs (lncRNAs) represent a group of ncRNAs with more than 200 nucleotides. These RNAs can specifically regulate gene expression at both the transcriptional and the post-transcriptional levels, and increasing evidence indicates that they play vital roles in a variety of disease-related cellular processes. The lncRNA GAS8 antisense RNA 1 (GAS8-AS1, also known as C16orf3) is located in the second intron of GAS8 and has been reported to be both abnormally expressed in several diseases and closely correlated with many clinical characteristics. GAS8-AS1 has been shown to affect many biological functions, including cell proliferation, migration, invasiveness, and autophagy using several signaling pathways. In this review, we have summarized current studies on GAS8-AS1 roles in disease and discuss its potential clinical utility. GAS8-AS1 may be a promising biomarker for both diagnoses and prognoses, and a novel target for many disease therapies.

Keywords: Biological function; Biomarker; GAS8-AS1; LncRNA; Mechanisms.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Diagnosis
  • Disease / genetics*
  • Humans
  • Prognosis
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers
  • GAS8-AS1 protein, human
  • RNA, Long Noncoding